Characterization of the apolipoprotein B mRNA editing enzyme: no similarity to the proposed mechanism of RNA editing in kinetoplastid protozoa
- PMID: 1649450
- PMCID: PMC328381
- DOI: 10.1093/nar/19.13.3569
Characterization of the apolipoprotein B mRNA editing enzyme: no similarity to the proposed mechanism of RNA editing in kinetoplastid protozoa
Abstract
Intestinal apolipoprotein B mRNA is edited at nucleotide 6666 by a C to U transition resulting in a translational stop codon. The enzymatic properties of the editing activity were characterised in vitro using rat enterocyte cytosolic extract. The editing activity has no nucleotide or ion cofactor requirement. It shows substrate saturation with an apparent Km for the RNA substrate of 2.2 nM. The editing enzyme requires no lag period prior to catalysis, and does not assemble into a higher order complex on the RNA substrate. In crude cytosolic extract editing activity is completely abolished by treatment with micrococcal nuclease or RNAse A. Partially purified editing enzyme is no longer sensitive to nucleases, but is inhibited in a dose dependent manner by nuclease inactivated crude extract. The buoyant density of partially purified editing enzyme is 1.3 g/ml, that of pure protein. Therefore, the apolipoprotein B mRNA editing activity consists of a well defined enzyme with no RNA component. The nuclease sensitivity in crude cytosolic extract is explained by the generation of inhibitors for the editing enzyme. The editing of apo B mRNA has little similarity to complex mRNA processing events such as splicing and unlike editing in kinetoplastid protozoa does not utilise guide RNAs.
Similar articles
-
Evolution of intestinal apolipoprotein B mRNA editing. Chicken apolipoprotein B mRNA is not edited, but chicken enterocytes contain in vitro editing enhancement factor(s).J Biol Chem. 1992 Oct 15;267(29):21265-72. J Biol Chem. 1992. PMID: 1400437
-
The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase.J Biol Chem. 1993 Oct 5;268(28):20709-12. J Biol Chem. 1993. PMID: 8407891
-
Apolipoprotein B messenger RNA editing: insights into the molecular regulation of post-transcriptional cytidine deamination.Curr Opin Lipidol. 1995 Apr;6(2):70-4. doi: 10.1097/00041433-199504000-00002. Curr Opin Lipidol. 1995. PMID: 7773570 Review.
-
RNA editing: exploring one mode with apolipoprotein B mRNA.Bioessays. 1993 Jan;15(1):33-41. doi: 10.1002/bies.950150106. Bioessays. 1993. PMID: 8466474 Review.
-
Apobec-1 interacts with a 65-kDa complementing protein to edit apolipoprotein-B mRNA in vitro.J Biol Chem. 1996 Nov 8;271(45):28294-9. doi: 10.1074/jbc.271.45.28294. J Biol Chem. 1996. PMID: 8910449
Cited by
-
A sequence-specific RNA-binding protein complements apobec-1 To edit apolipoprotein B mRNA.Mol Cell Biol. 1998 Aug;18(8):4426-32. doi: 10.1128/MCB.18.8.4426. Mol Cell Biol. 1998. PMID: 9671452 Free PMC article.
-
Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.Mol Cell Biol. 2000 Mar;20(5):1846-54. doi: 10.1128/MCB.20.5.1846-1854.2000. Mol Cell Biol. 2000. PMID: 10669759 Free PMC article.
-
Assembly of lipoprotein particles containing apolipoprotein-B: structural model for the nascent lipoprotein particle.Biophys J. 2005 Apr;88(4):2789-800. doi: 10.1529/biophysj.104.046235. Epub 2005 Jan 14. Biophys J. 2005. PMID: 15653747 Free PMC article.
-
RNA Editors, Cofactors, and mRNA Targets: An Overview of the C-to-U RNA Editing Machinery and Its Implication in Human Disease.Genes (Basel). 2018 Dec 27;10(1):13. doi: 10.3390/genes10010013. Genes (Basel). 2018. PMID: 30591678 Free PMC article. Review.
-
The cytidine deaminase APOBEC3A regulates nucleolar function to promote cell growth and ribosome biogenesis.PLoS Biol. 2024 Jul 8;22(7):e3002718. doi: 10.1371/journal.pbio.3002718. eCollection 2024 Jul. PLoS Biol. 2024. PMID: 38976757 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources